| 发明名称 |
3, 5-disubstituted and 3, 4, 5-trisubstituted 2-isoxazolines and isoxazoles, process for their preparation and their use as pharmaceuticals |
| 摘要 |
PCT No. PCT/EP95/00784 Sec. 371 Date Nov. 19, 1996 Sec. 102(e) Date Nov. 19, 1996 PCT Filed Mar. 3, 1995 PCT Pub. No. WO95/24397 PCT Pub. Date Sep. 14, 1995A compound having the formula (I), a physiologically tolerable salt of the compound having the formula (I) and/or a steroisomeric form of the compound having the formula (I), in which one residue R1 or R2 stands for the formula (II), are suitable for preparing medicaments for the therapy of inflammations, asthma, rheumatoid diseases and auto-immune diseases.
|
| 申请公布号 |
US5814627(A) |
申请公布日期 |
1998.09.29 |
| 申请号 |
US19960704743 |
申请日期 |
1996.11.19 |
| 申请人 |
HOECHST AKTIENEGESELLSCHAFT |
发明人 |
SCHWAB, WILFRIED;ANAGNOSTOPULOS, HIRISTO;BARTLETT, ROBERT RYDER;SCHLEYERBACH, RUDOLF;WEITHMANN, KLAUS ULRICH |
| 分类号 |
A61K31/41;A61K31/42;A61K31/423;A61K31/495;A61K31/496;A61K31/535;A61K31/5377;A61P11/00;A61P29/00;A61P37/00;C07C205/51;C07D261/04;C07D261/08;C07D261/18;C07D261/20;C07D263/30;C07D413/04;C07D413/12;C07D417/04;C07F9/653;(IPC1-7):A61K31/42 |
主分类号 |
A61K31/41 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
